Cannabis can ease the journey through cancer treatment—but it is not without risks, especially when it comes to immunotherapy.
AI in medicine isn’t about replacing us—it’s about giving us back the time to be fully present, both with our patients and in our lives.
Coming home is less about geography and more about gratitude for the life we’re building, one step at a time.
A five-minute call with your oncology expert can save weeks of wasted time—and prevent costly missteps.
When immune therapy clears cancer, the real question for resectable tumors becomes: Do we still need to resect?
From early-stage to brain metastases, ASCO’s latest melanoma abstracts spotlight the growing power of targeted and immune-based therapies across disease stages.
ctDNA is helping us track what truly matters—real-time, personalized signals that guide smarter decisions in cancer care.
This past weekend was Father’s Day, and I had the joy of spending it the way it should be spent—surrounded by family. We made a full day of it at the new Epic Universe theme park, something we haven’t done in years. Usually, our theme park visits are quick—annual pass holders popping in for a …
Immunotherapy’s success may hinge on what we preserve, not just what we prescribe.
Five groundbreaking trials from the ASCO Plenary are transforming cancer care—ushering in biomarker-led immunotherapy across multiple disease types.